BMS Latest to Quit Consumer Health with UPSA Divestment
By Jawala Prasad & Michelle Liu
Pharma Deals Review: Vol 2019 Issue 1 (Table of Contents)
Published: 10 Jan-2019
DOI: 10.3833/pdr.v2019.i1.2393 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to streamline its focus towards its core business, Bristol-Myers Squibb has decided to divest its consumer health business, Union Pharmacologique Scientifique Appliquee (UPSA), following a strategic review announced in June 2018...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS